Yongqing Li Selected Research

Lipopolysaccharides

5/2021	Cl-Amidine Improves Survival and Attenuates Kidney Injury in a Rabbit Model of Endotoxic Shock.
8/2020	Inhibition of PAD2 Improves Survival in a Mouse Model of Lethal LPS-Induced Endotoxic Shock.
1/2019	Citrullinated Histone H3 as a Therapeutic Target for Endotoxic Shock in Mice.
8/2018	Inhibition of peptidylarginine deiminase alleviates LPS-induced pulmonary dysfunction and improves survival in a mouse model of lethal endotoxemia.
1/2017	CitH3: a reliable blood biomarker for diagnosis and treatment of endotoxic shock.
4/2015	Protective effect of suberoylanilide hydroxamic acid against lipopolysaccharide-induced liver damage in rodents.
8/2014	Citrullinated histone H3: a novel target for the treatment of sepsis.
8/2013	Novel pharmacologic treatment attenuates septic shock and improves long-term survival.
12/2012	Histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates Toll-like receptor 4 signaling in lipopolysaccharide-stimulated mouse macrophages.
9/2012	Creating a "pro-survival" phenotype through epigenetic modulation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yongqing Li Research Topics

Disease

41	Hemorrhagic Shock 01/2021 - 04/2006
35	Hemorrhage 01/2022 - 04/2006
31	Shock 01/2022 - 03/2008
20	Wounds and Injuries (Trauma) 01/2023 - 04/2008
19	Neoplasms (Cancer) 03/2024 - 03/2003
18	Infections 01/2023 - 05/2010
17	Hypoxia (Hypoxemia) 04/2022 - 04/2008
16	Sepsis (Septicemia) 01/2022 - 08/2014
15	Inflammation (Inflammations) 11/2022 - 08/2010
15	Traumatic Brain Injuries (Traumatic Brain Injury) 11/2022 - 12/2013
13	Septic Shock (Toxic Shock Syndrome) 02/2021 - 11/2009
9	Multiple Trauma (Multiple Injuries) 11/2020 - 12/2013
6	Carcinoma (Carcinomatosis) 01/2022 - 05/2002
6	Acute Lung Injury 08/2018 - 02/2012
5	Marek Disease (Marek's Disease) 12/2022 - 05/2010
5	Breast Neoplasms (Breast Cancer) 01/2021 - 08/2003
5	Hypothermia 06/2015 - 08/2006
4	Influenza in Birds (Avian Flu) 01/2023 - 05/2010
4	Melanoma (Melanoma, Malignant) 01/2021 - 08/2005
3	Non-alcoholic Fatty Liver Disease 09/2023 - 04/2021
3	Neoplasm Metastasis (Metastasis) 09/2022 - 01/2015
3	Carcinogenesis 01/2022 - 10/2004
3	Myocardial Infarction 10/2020 - 12/2015
3	Ischemia 10/2020 - 02/2012
3	Endotoxemia 08/2020 - 08/2013
3	Atrophy 11/2016 - 08/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 07/2016 - 07/2002
2	Liver Neoplasms (Liver Cancer) 01/2024 - 04/2022
2	Fatty Liver 09/2023 - 04/2021
2	Latent Infection 12/2022 - 01/2018
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2022 - 01/2022
2	Lung Neoplasms (Lung Cancer) 01/2022 - 03/2020
2	Virus Diseases (Viral Diseases) 01/2021 - 08/2008

Drug/Important Bio-Agent (IBA)

32	Histone Deacetylase InhibitorsIBA 01/2021 - 06/2007
28	Proteins (Proteins, Gene)FDA Link 11/2022 - 03/2003
28	Valproic Acid (Depakote)FDA LinkGeneric 10/2021 - 03/2008
16	Histones (Histone)IBA 05/2021 - 06/2007
15	Saline SolutionIBA 01/2021 - 02/2008
14	LipopolysaccharidesIBA 05/2021 - 08/2008
14	Histone Deacetylases (Histone Deacetylase)IBA 01/2021 - 06/2007
13	salicylhydroxamic acid (SHAM)IBA 02/2016 - 06/2007
12	Vorinostat FDA Link 04/2015 - 11/2009
11	CytokinesIBA 12/2022 - 08/2005
10	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2010
10	Protein-Arginine DeiminasesIBA 01/2023 - 08/2014
8	AntigensIBA 03/2012 - 05/2002
7	EnzymesIBA 09/2023 - 08/2010
7	Histone Deacetylase 6IBA 11/2020 - 07/2015
7	SolutionsIBA 12/2017 - 08/2006
6	VaccinesIBA 01/2023 - 12/2006
6	Ringer's LactateIBA 01/2022 - 04/2006
6	Transcription Factors (Transcription Factor)IBA 01/2021 - 07/2002
6	Caspase 3 (Caspase-3)IBA 01/2019 - 07/2009
6	Lactic Acid (Lactate)FDA LinkGeneric 12/2013 - 08/2009
5	tubastatin AIBA 12/2018 - 07/2015
4	Interleukin-6 (Interleukin 6)IBA 12/2022 - 01/2015
4	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2015
4	Protein Isoforms (Isoforms)IBA 11/2020 - 01/2018
4	TubulinIBA 10/2020 - 01/2016
4	Hydroxyethyl Starch Derivatives (Pentastarch)FDA Link 01/2017 - 04/2006
4	Oncogene Proteins (Oncogene Protein)IBA 06/2016 - 08/2003
4	Pyruvic Acid (Pyruvate)IBA 12/2013 - 04/2006
4	beta CateninIBA 08/2009 - 05/2002
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2024 - 12/2016
3	Monoclonal AntibodiesIBA 01/2023 - 01/2019
3	ChemokinesIBA 04/2022 - 04/2007
3	Mitogen-Activated Protein KinasesIBA 01/2022 - 07/2012
3	CalciumIBA 10/2021 - 01/2019
3	N- alpha- benzoyl- N5- (2- chloro- 1- iminoethyl)- L- ornithine amideIBA 05/2021 - 08/2014
3	Blood Proteins (Serum Proteins)IBA 04/2021 - 03/2010
3	Phosphotransferases (Kinase)IBA 01/2019 - 09/2010
3	ACY1083IBA 01/2019 - 01/2018
3	Glycoproteins (Glycoprotein)IBA 12/2017 - 05/2002
3	EpitopesIBA 12/2017 - 05/2004
3	Peptides (Polypeptides)IBA 06/2010 - 05/2004
3	KetonesIBA 02/2008 - 04/2006
3	Mucin-1 (CA 15-3 Antigen)IBA 11/2003 - 05/2002
2	Sincalide FDA Link 01/2024 - 01/2022
2	MethyltransferasesIBA 09/2023 - 02/2015
2	6-methyladenineIBA 09/2023 - 01/2021
2	Neutralizing AntibodiesIBA 01/2023 - 12/2017
2	Cadherins (E-Cadherin)IBA 09/2022 - 01/2022
2	Long Noncoding RNAIBA 01/2022 - 01/2022
2	LipidsIBA 01/2022 - 08/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 08/2013
2	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2004
2	CateninsIBA 01/2022 - 01/2021
2	Competitive Endogenous RNAIBA 01/2022 - 01/2022
2	Proteoglycans (Proteoglycan)IBA 01/2022 - 01/2022
2	Adenosine Triphosphate (ATP)IBA 10/2021 - 10/2020
2	ImmunosorbentsIBA 04/2021 - 08/2010
2	Basic Helix-Loop-Helix Transcription FactorsIBA 04/2021 - 05/2006

Therapy/Procedure

36	Resuscitation 01/2022 - 04/2006
11	Therapeutics 01/2023 - 08/2005
8	Ligation 10/2020 - 08/2013
7	Punctures 12/2018 - 08/2013
4	Cardiopulmonary Bypass (Heart-Lung Bypass) 05/2010 - 08/2006
3	Lasers (Laser) 09/2018 - 03/2010
2	Segmental Mastectomy (Lumpectomy) 07/2021 - 01/2021
2	Drug Therapy (Chemotherapy) 05/2021 - 12/2015